THE VEDOLIZUMAB CLINICAL DECISION SUPPORT TOOL FOR CROHN'S DISEASE EFFECTIVELY PREDICTS CLINICAL REMISSION AT 54 WEEKS IN A "REAL WORLD" SETTING
Konstantina Chalakatevaki 1
Georgios Kokkotis
Evgenia Papathanasiou 2
Nikolaos Kioulos
Michalis Gizis
Matina Lydia Chatzinikolaou
Ioannis Koutsounas
Spyridon Michopoulos
Evanthia Zampeli
Giorgos Bamias
1 3rd Department of Internal Medicine "Sotiria" Hospital, National and Kapodistrian University of Athens, Athens, Greece
2 Alexandra Hospital, Athens, Greece
Session
IBD (Posters)
Conference
UEG Week 2022
Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]